Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban.


Journal

Case reports in cardiology
ISSN: 2090-6404
Titre abrégé: Case Rep Cardiol
Pays: United States
ID NLM: 101576452

Informations de publication

Date de publication:
2022
Historique:
received: 18 03 2022
accepted: 08 07 2022
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 2 8 2022
Statut: epublish

Résumé

Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported. Prospective randomised control trials should be conducted in patients with left ventricular thrombus to compare anticoagulants, assess the efficacy and safety of DOACs, and evaluate uninterrupted DOAC versus transient withdrawal for cardiac device procedures.

Sections du résumé

Background UNASSIGNED
Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported.
Conclusion UNASSIGNED
Prospective randomised control trials should be conducted in patients with left ventricular thrombus to compare anticoagulants, assess the efficacy and safety of DOACs, and evaluate uninterrupted DOAC versus transient withdrawal for cardiac device procedures.

Identifiants

pubmed: 35911864
doi: 10.1155/2022/8156942
pmc: PMC9334074
doi:

Types de publication

Case Reports

Langues

eng

Pagination

8156942

Informations de copyright

Copyright © 2022 Azhar Farooqui et al.

Déclaration de conflit d'intérêts

All authors declare that they have no conflicts of interest.

Références

Am J Ther. 2020 Nov/Dec;27(6):e584-e590
pubmed: 30730331
JACC Cardiovasc Imaging. 2011 Jul;4(7):702-12
pubmed: 21757159
Am J Cardiol. 2004 Feb 15;93(4):500-3
pubmed: 14969636
Eur Heart J. 2018 Nov 21;39(44):3973-3979
pubmed: 30462279
J Am Coll Cardiol. 2019 Apr 23;73(15):2007-2009
pubmed: 30846340
Am J Cardiol. 2019 Aug 1;124(3):367-372
pubmed: 31126539
Am J Cardiovasc Dis. 2017 Nov 01;7(5):98-101
pubmed: 29181265
J Am Coll Cardiol. 2020 Apr 14;75(14):1676-1685
pubmed: 32273033
CASE (Phila). 2020 Oct 03;4(6):500-503
pubmed: 33376842
J Thromb Thrombolysis. 2016 Apr;41(3):365-73
pubmed: 26202909

Auteurs

Azhar Farooqui (A)

Department of Cardiology, Kettering General Hospital NS Foundation Trust, Rothwell Road, Kettering, NN16 8UZ, UK.
University Hospitals of Leicester NHS Trust, Leicester, UK.

Tin Lwin (T)

Department of Cardiology, Kettering General Hospital NS Foundation Trust, Rothwell Road, Kettering, NN16 8UZ, UK.
Department of Cardiology, Castle Hill Hospital, UK.

Daniel Costa (D)

Department of Cardiology, Kettering General Hospital NS Foundation Trust, Rothwell Road, Kettering, NN16 8UZ, UK.

Simon Hetherington (S)

Department of Cardiology, Kettering General Hospital NS Foundation Trust, Rothwell Road, Kettering, NN16 8UZ, UK.
University of Leicester, Leicester, UK.

Raj Mattu (R)

Department of Cardiology, Kettering General Hospital NS Foundation Trust, Rothwell Road, Kettering, NN16 8UZ, UK.
University College London, London, UK.

Classifications MeSH